// App-Quantinova.ai

1416 : Persistence of Cytogenetic Abnormalities at Complete Remission Is Not Prognostic for Relapse-Free or Overall Survival in Adult Patients with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Nicholas J. Short

Principal Investigators

  • Hagop M. Kantarjian

  • Elias Jabbour

  • Tapan Kadia

  • Naval Daver

  • Gautam Borthakur

  • Susan -Brien

  • Stefan Faderl

  • Jan A. Burger

  • Rebecca Garris

  • Wei Qiao

  • Xuelin Huang

  • Nitin Jain

  • Marina Konopleva

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • John Theurer Cancer Center, Hackensack, NJ

  • University of California, Irvine, Fullerton, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved